Cargando…
Nitric oxide and pulmonary arterial hypertension
The pathogenesis of pulmonary arterial hypertension remains undefined. Changes in the expression and effects mediated by a number of vasoactive factors have been implicated to play a role in the onset and progression of the disease. The source of many of these mediators, such as nitric oxide (NO), p...
Autores principales: | Chester, Adrian H., Yacoub, Magdi H., Moncada, Salvador |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871404/ https://www.ncbi.nlm.nih.gov/pubmed/29644226 http://dx.doi.org/10.21542/gcsp.2017.14 |
Ejemplares similares
-
The role of endothelin-1 in pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2014) -
Nitric oxide and pulmonary hypertension
por: Sim, Ji-Yeon
Publicado: (2010) -
Chronic thromboembolic pulmonary hypertension – still evolving
por: Gerges, Mario, et al.
Publicado: (2020) -
Upregulated Genes In Sporadic, Idiopathic Pulmonary Arterial Hypertension
por: Edgar, Alasdair J, et al.
Publicado: (2006) -
Combination Therapy in Pulmonary Arterial Hypertension—Targeting the
Nitric Oxide and Prostacyclin Pathways
por: Mandras, Stacy, et al.
Publicado: (2021)